|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements |
|
For The Year Ended 31 July 2018 |
|
for |
|
ARISE PHARMA LTD |
|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements |
|
For The Year Ended 31 July 2018 |
|
for |
|
ARISE PHARMA LTD |
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
|
|
|
|
|
Contents of the Financial Statements |
For The Year Ended 31 July 2018 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Balance Sheet | 2 |
|
Notes to the Financial Statements | 4 |
|
ARISE PHARMA LTD |
|
Company Information |
For The Year Ended 31 July 2018 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
Accountants & Tax Advisers |
79 College Road |
Harrow |
Middlesex |
HA1 1BD |
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Balance Sheet |
31 July 2018 |
|
31.7.18 | 31.7.17 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
|
|
Investments | 5 |
|
|
|
|
|
CURRENT ASSETS |
Debtors | 6 |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 7 |
|
|
NET CURRENT (LIABILITIES)/ASSETS | ( |
) |
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CREDITORS |
Amounts falling due after more than one
year |
8 |
|
|
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
Called up share capital |
|
|
Retained earnings |
|
|
SHAREHOLDERS' FUNDS |
|
|
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) |
ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and |
(b) |
preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Balance Sheet - continued |
31 July 2018 |
|
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
|
The financial statements were approved by the Board of Directors on
|
|
|
|
|
|
|
|
|
|
|
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Notes to the Financial Statements |
For The Year Ended 31 July 2018 |
|
1. | STATUTORY INFORMATION |
|
ARISE PHARMA LTD is a
|
company's registered number and registered office address can be found on the Company Information page. |
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, |
value added tax and other sales taxes. |
|
Tangible fixed assets |
|
Plant and machinery etc | - |
|
|
Investments in associates |
Investments in associate undertakings are recognised at cost. |
|
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to |
the extent that it relates to items recognised in other comprehensive income or directly in equity. |
|
Current or deferred taxation assets and liabilities are not discounted. |
|
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or |
substantively enacted by the balance sheet date. |
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance |
sheet date. |
|
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from |
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that |
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the |
timing difference. |
|
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they |
will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
|
3. | EMPLOYEES AND DIRECTORS |
|
The average number of employees during the year was NIL (2017 - NIL). |
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Notes to the Financial Statements - continued |
For The Year Ended 31 July 2018 |
|
4. | TANGIBLE FIXED ASSETS |
Plant and |
machinery |
etc |
£ |
COST |
At 1 August 2017 |
and 31 July 2018 |
|
DEPRECIATION |
At 1 August 2017 |
|
Charge for year |
|
At 31 July 2018 |
|
NET BOOK VALUE |
At 31 July 2018 |
|
At 31 July 2017 |
|
|
5. | FIXED ASSET INVESTMENTS |
|
31.7.18 | 31.7.17 |
£ | £ |
Participating interests |
|
|
Loans to undertakings in which the company
has a participating interest |
|
|
Other loans |
|
|
|
|
|
Additional information is as follows: |
Interest |
in |
associate |
£ |
COST |
At 1 August 2017 |
and 31 July 2018 |
|
NET BOOK VALUE |
At 31 July 2018 |
|
At 31 July 2017 |
|
Loans to | Other |
associates | loans | Totals |
£ | £ | £ |
At 1 August 2017 |
|
|
|
New in year |
|
|
|
At 31 July 2018 |
|
|
|
ARISE PHARMA LTD (REGISTERED NUMBER: 08629933) |
|
Notes to the Financial Statements - continued |
For The Year Ended 31 July 2018 |
|
6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.7.18 | 31.7.17 |
£ | £ |
Trade debtors |
|
|
Other debtors |
|
|
|
|
|
7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.7.18 | 31.7.17 |
£ | £ |
Trade creditors |
|
|
Taxation and social security |
|
|
Other creditors |
|
|
|
|
|
8. |
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR |
31.7.18 | 31.7.17 |
£ | £ |
Other creditors |
|
|
|
Unsecured Directors Loan |
|
Unsecured Director's Loan of £154,619 given by Mr Jaykumar Pradyuman Jani was interest free and |
subordinated in favour of third party creditors. The loan is repayable after 5 years. |